Log in or Sign up for Free to view tailored content for your specialty!
Stroke/Vascular Neurology News
FDA proposes cap on nicotine levels in cigarettes
The FDA has proposed limiting the level of nicotine in cigarettes and other combusted tobacco products like cigars and pipe tobacco to make them “minimally or nonaddictive,” according to a press release from the agency.
AAN shares 12 patient-provider conversation starters about brain health
In a newly published paper, the American Academy of Neurology promoted 12 key concepts for patients and providers to successfully promote and maintain brain health.
Nasal spray for brain cancer, Alzheimer’s blood test: Top neurology Q&As of 2024
Healio Neurology looks back at the most popular Q&As with industry and specialty experts from the past year.
Log in or Sign up for Free to view tailored content for your specialty!
Q&A: New stroke guidance highlights risk for women with endometriosis, early menopause
New guidance on primary prevention of stroke from the American Heart Association and American Stroke Association states women with endometriosis and early menopause are at higher risk, requiring a thorough history and tailored management.
SGLT2s, GLP-1s may improve mortality, CV event risk after stroke
CHICAGO — Use of an SGLT2 inhibitor or GLP-1 receptor agonist after stroke may improve mortality and lower subsequent risk for heart attack and another stroke, a speaker reported.
Blood pressure drug may lower risk for post-stroke epilepsy
LOS ANGELES — Individuals with hypertension and stroke who were prescribed angiotensin receptor blockers had a significantly lower risk for post-stroke epilepsy than those prescribed other antihypertension medications, according to new research.
Cardiovascular factors, including hypertension, associated with risk for severe stroke
Hypertension, atrial fibrillation and smoking were most strongly associated with an increased risk for severe compared with non-severe stroke, according to analysis from the INTERSTROKE study.
Rivaroxaban fails to prevent cognitive decline, stroke in younger adults with AF
CHICAGO — In the BRAIN-AF trial, daily rivaroxaban did not reduce the incidence of cognitive decline, stroke or transient ischemic attack, compared with placebo, among younger patients with atrial fibrillation and low stroke risk.
Cardiovascular health in middle age strongly associated with brain health in later years
Cardiovascular health of middle-aged adults was significantly associated with the risk of poor brain health later in life, according to a study published in Neurology.
Catch up on the latest stroke research in observance of World Stroke Day
October 29 is World Stroke Day, which aims to raise awareness of the condition and how to prevent it.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read